š”š²šš š¦ššŗšŗš®šæš
ā¢ China has been the preferred location for pharmaceutical research and manufacturing services for nearly 20 years, but increasing tensions with the country have prompted companies to consider using manufacturers in India.
ā¢ Four of India's largest CDMOs have seen increased interest and requests from Western pharma companies, including major multinationals.
ā¢ India is seeking a bigger foothold in the pharma services sector, but concerns over lax oversight persist.